Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Ewing Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Study coordinator · dengchzh@sysucc.org.cn

Study leads

Jin Wang, MD
Principal Investigator
Sun Yat-Sen University Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Metastatic Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Phoenix, United States

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Ewing Sarcoma · Colorectal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · Beverly Hills, United States

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Osteosarcoma · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE2

Tampa, United States · Hershey, United States

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Atypical Teratoid/Rhabdoid Tumor · Embryonal Tumor With Multilayered Rosettes · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Little Rock, United States